GS

Gautham Sanker Parameswaran Nair

Active Director Director DIN 11268005
DIN 11268005 First appointment Aug 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Gautham Sanker Parameswaran Nair

Data last updated:

Gautham Sanker Parameswaran Nair is a Director at Madhura Medipark Private Limited (since 2025).

DIN 11268005
Primary Designation Director
First Appointment 29 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Madhura Medipark Private Limited U86100TZ2025PTC035841
Director29 Aug 20252025Active

Board colleagues of Gautham Sanker Parameswaran Nair

Directorship timeline

Open interactive timeline →
Madhura Medipark Private Limited
Premium access

Shareholding and investment profile for Gautham Sanker Parameswaran Nair

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gautham Sanker Parameswaran Nair

Gautham Sanker Parameswaran Nair currently holds 1 directorship: Madhura Medipark Private Limited (Director, since 29 Aug 2025).

Gautham Sanker Parameswaran Nair was first appointed on 29 Aug 2025 as Director at Madhura Medipark Private Limited.

The current boards of Gautham Sanker Parameswaran Nair's companies include Amal Shanker Parameswaran Nair (Madhura Medipark Private Limited), Padmakumari Sarojiniamma (Madhura Medipark Private Limited), Parameswaran Nair Narayanan Nair (Madhura Medipark Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available